Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
Spotlight
GLP-1s
Interviews
FDA
Strategy
Generics
Biosimilars
Value Added Medicines
Business
Deals
Earnings
Manufacturing
Policy & Regulation
Regulatory Landscape
Drug Pricing
IP & Litigation
Tools & Trackers
What's Next?
Who's Hired?
UK Pricing Tracker
Company Rankings
Podcasts
Conference Coverage
Partner Insights
Generics Bulletin Perspectives
Exploring market-shifting topics for the off-patent sector.
View
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
Teva: Here’s How We Plan To Solve ‘Litigation Challenges’
Materials ‘Deliberately Not Handed Over Before Closing Remarks,’ Teva Says
Jan 12 2022
•
By
Dean Rudge
Teva was recently found liable by a jury in New York • Source: Alamy/Andrii Yalanskyi
More from Legal & IP
More from Generics Bulletin